Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Biomea Fusion posts 15% weight loss in primate model as BMF-650 nears IND for oral GLP-1 therapy Biomea Fusion’s BMF-650 shows 15% weight loss in primates. Find out why investors are watching its IND filing and Phase I trial timeline for obesity treatment. byPallavi MadhirajuJune 18, 2025